Dapeng Li Selected Research

Enzymes

5/2022	The Glutaminase Inhibitor Compound 968 Exhibits Potent in vitro and in vivo Anti-tumor Effects in Endometrial Cancer.
9/2017	Dietary supplementation with selenium yeast and tea polyphenols improve growth performance and nitrite tolerance of Wuchang bream (Megalobrama amblycephala).
4/2017	Correlation Between Expression of High Temperature Requirement Serine Protease A1 (HtrA1) in Nucleus Pulposus and T2 Value of Magnetic Resonance Imaging.
4/2008	Acute effects of microcystins on the transcription of antioxidant enzyme genes in crucian carp Carassius auratus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dapeng Li Research Topics

Disease

48	Neoplasms (Cancer) 07/2022 - 05/2006
19	Infections 02/2022 - 02/2005
11	Inflammation (Inflammations) 03/2022 - 01/2010
11	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
11	Body Weight (Weight, Body) 01/2022 - 06/2007
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2022 - 05/2014
7	COVID-19 01/2022 - 01/2021
7	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2007
6	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2015
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2017
5	Virus Diseases (Viral Diseases) 03/2021 - 03/2016
5	Carcinoma (Carcinomatosis) 05/2017 - 10/2009
4	Weight Gain 01/2022 - 09/2017
4	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 04/2018
4	Intervertebral Disc Degeneration 01/2018 - 01/2014
3	Neuroinflammatory Diseases 03/2022 - 10/2020
3	Obesity 01/2022 - 10/2019
3	Adenocarcinoma of Lung 01/2022 - 06/2020
3	Carcinogenesis 01/2022 - 01/2012
3	Pain (Aches) 03/2021 - 09/2015
3	Reinfection 01/2021 - 01/2017
3	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 12/2017
3	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 02/2005
3	Fibrosis (Cirrhosis) 01/2020 - 12/2013
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2015 - 10/2009
2	Cognitive Dysfunction 03/2022 - 10/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 10/2020
2	Non-alcoholic Fatty Liver Disease 11/2021 - 10/2019
2	Lung Neoplasms (Lung Cancer) 09/2021 - 01/2012
2	Hypertrophy 08/2021 - 01/2015
2	Breakthrough Infections 05/2021 - 01/2021
2	Edema (Dropsy) 02/2021 - 01/2021
2	Pneumonia (Pneumonitis) 02/2021 - 01/2021
2	Asthma (Bronchial Asthma) 01/2021 - 01/2018
2	Hypertension (High Blood Pressure) 11/2020 - 10/2020
2	Overweight 10/2020 - 01/2018
2	Lymphatic Metastasis 01/2020 - 06/2014
2	Papillary Thyroid Cancer 01/2020 - 01/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019 - 02/2005
2	Zika Virus Infection 10/2019 - 01/2018
2	Wounds and Injuries (Trauma) 11/2018 - 01/2018
2	Liver Neoplasms (Liver Cancer) 01/2018 - 12/2010

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 11/2021 - 02/2005
15	VaccinesIBA 02/2022 - 07/2014
11	Messenger RNA (mRNA)IBA 08/2021 - 01/2013
9	Pharmaceutical PreparationsIBA 03/2021 - 12/2007
8	Biomarkers (Surrogate Marker)IBA 10/2022 - 09/2019
8	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2011
7	Neutralizing AntibodiesIBA 02/2022 - 04/2013
6	AntibodiesIBA 01/2022 - 01/2019
5	AntioxidantsIBA 03/2022 - 04/2008
5	Sirtuin 1IBA 03/2022 - 04/2018
5	CytokinesIBA 08/2021 - 08/2012
5	Biological ProductsIBA 01/2020 - 12/2007
5	MicrocystinsIBA 10/2011 - 06/2007
4	EnzymesIBA 05/2022 - 04/2008
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 11/2015
4	PolyphenolsIBA 01/2022 - 09/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2005
4	Interleukin-6 (Interleukin 6)IBA 11/2021 - 08/2012
4	Antiviral Agents (Antivirals)IBA 04/2021 - 01/2017
3	CrizotinibIBA 01/2022 - 06/2020
3	NitrogenIBA 01/2022 - 06/2021
3	TeaIBA 01/2022 - 09/2017
3	Cadmium Chloride (Cadmium Dichloride)IBA 12/2021 - 10/2020
3	Therapeutic UsesIBA 11/2021 - 01/2018
3	Peptides (Polypeptides)IBA 01/2020 - 05/2006
3	NitritesIBA 11/2018 - 09/2017
3	Interleukin-17 (Interleukin 17)IBA 01/2018 - 01/2010
2	Cadherins (E-Cadherin)IBA 05/2022 - 01/2013
2	DH1047IBA 01/2022 - 04/2021
2	Saline SolutionIBA 01/2022 - 09/2015
2	FlavonoidsIBA 01/2022 - 02/2021
2	CreatinineIBA 01/2022 - 08/2021
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 08/2021
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	Histones (Histone)IBA 01/2022 - 05/2013
2	Palmitic Acid (Hexadecanoic Acid)IBA 01/2022 - 11/2021
2	QuercetinIBA 01/2022 - 01/2019
2	SeleniumIBA 08/2021 - 09/2017
2	Tyrosine Kinase InhibitorsIBA 07/2021 - 01/2020
2	osimertinibIBA 07/2021 - 06/2020
2	remdesivirIBA 04/2021 - 01/2021
2	Monoclonal AntibodiesIBA 04/2021 - 01/2021
2	Blocking AntibodiesIBA 02/2021 - 01/2021
2	Fc Receptors (Fc Receptor)IBA 02/2021 - 01/2021
2	Celecoxib (Celebrex)FDA Link 11/2020 - 05/2017
2	CadmiumIBA 10/2020 - 07/2020
2	EstersIBA 12/2019 - 09/2019
2	Broadly Neutralizing AntibodiesIBA 10/2019 - 01/2017
2	Carcinoembryonic AntigenIBA 01/2019 - 10/2009
2	Polymethyl Methacrylate (Sol)IBA 09/2018 - 06/2016
2	HydrogelsIBA 09/2018 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 04/2018 - 10/2017

Therapy/Procedure

13	Therapeutics 07/2022 - 05/2014
9	Drug Therapy (Chemotherapy) 01/2022 - 07/2016
5	Immunotherapy 01/2022 - 01/2010
4	Radiotherapy 07/2022 - 07/2016
3	Chemoradiotherapy 01/2022 - 05/2014
2	Injections 07/2021 - 09/2015